Navitas Semiconductor Corporation — Q1 2023 Form 10-Q
Business context and reporting period. The filing covers the three months ended March 31, 2023. Navitas designs and markets GaN and SiC power semiconductors, controllers and digital isolators, using a fabless manufacturing model. Its products serve mobile charging and other consumer, data-center, solar and electric-vehicle applications. Results include GeneSiC, acquired in August 2022; the prior-year comparison does not include GeneSiC for the full quarter.
Financial performance and liquidity
| Metric | Q1 2023 | Q1 2022 |
|---|---|---|
| Revenue | $13.4 million | $6.7 million |
| Gross profit / gross margin | $5.5 million / 41.1% | $3.0 million / 44.0% |
| Operating expenses | $41.0 million | $38.0 million |
| Operating loss | $35.5 million | $35.0 million |
| Net income (loss) | $(62.4) million | $79.8 million |
| Operating cash flow | $(7.9) million | $(10.6) million |
| Cash and cash equivalents at period end | $100.8 million | $253.8 million |
Revenue rose 98% year over year. Shipments increased 19% to 8.9 million units, while average selling price rose 78% to $1.46 per unit. Cost of revenue increased 108%, reflecting higher sales, GeneSiC and a reported 20% TSMC wafer-price increase; gross margin consequently declined. R&D was $17.4 million, up 31%, and SG&A was $19.1 million, down 22%. Stock-based compensation was $17.2 million.
The Q1 2023 net loss included a $27.8 million non-cash loss from remeasurement of earnout liabilities. Q1 2022 net income included $63.4 million of earnout fair-value gains and $51.8 million of warrant fair-value gains, making the net-income comparison substantially affected by non-operating valuation items. Q1 2023 interest income was $0.9 million.
Cash decreased $9.5 million from December 31, 2022. Investing cash use was $1.8 million, including a $1.0 million investment and $0.8 million of capital expenditures; financing provided $0.2 million. The term loan was fully repaid. Operating lease liabilities were $6.7 million at quarter-end; the company reported no other non-cancellable contractual arrangements due beyond one year. Management said existing cash was sufficient to fund operations, working capital and capital expenditures for the foreseeable future.
Changes, outlook and key risks
- Acquisitions and shares: In February 2023, Navitas completed the purchase of the remaining minority interest in its silicon-control-IC joint venture and related IP rights for $22.4 million in Navitas stock, issuing approximately 5.05 million shares. The acquired technology was recorded as a $4.4 million intangible asset.
- Outlook: No specific revenue or earnings guidance was provided. Management expects continued operating losses and negative operating cash flow, and expects R&D, SG&A and capital expenditures to increase as it expands products, headcount and customer reach.
- Concentration and supply: Three distributors accounted for 71% of Q1 revenue (35%, 19% and 17%). China represented 57% of revenue and Europe 28%. Navitas relies on a single foundry for GaN wafers and another single foundry for SiC wafers; significant supplier and manufacturing activity is in Taiwan.
- Accounting controls: Management concluded disclosure controls were ineffective because of material weaknesses in internal control over financial reporting, including limited technical accounting resources and insufficient segregation of duties. Remediation efforts were underway; management stated the financial statements fairly present results in all material respects.
- Other risks and contingencies: The filing highlights design-win and market-adoption uncertainty, customer order flexibility, acquisition integration, China exposure, supplier availability, potential dilution and tax complexity. No material litigation or material subsequent events were reported. The GeneSiC earnout liability was $0.4 million, with achievement considered remote; the company’s other earnout liability was subject to stock-price-driven fair-value changes.
Important facts for investors to verify
- Whether revenue growth and higher average selling prices are sustainable, and how much growth is attributable to GeneSiC.
- Whether gross margin can recover amid wafer-price increases and product-mix changes.
- Cash burn, cash runway and the timing of any need for additional financing or equity issuance.
- Distributor, geographic and foundry concentration, including exposure to Taiwan and China.
- Progress in remediating internal-control material weaknesses and any resulting reporting or restatement risks.
- The assumptions and future financial effects of earnout remeasurement, acquisition integration and substantial stock-based compensation.